TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
1.85
0.07 (3.93%)
At close: Sep 26, 2025, 3:59 PM
1.84
-0.54%
After-hours: Sep 26, 2025, 05:57 PM EDT
TScan Therapeutics Revenue
TScan Therapeutics reported an annual revenue of $2.82M, reflecting a -86.62% growth. For the quarter ending June 30, 2025, TScan Therapeutics generated $3.08M in revenue.
Revenue (ttm)
2.82M
Revenue Growth
-86.62%
Price / Sales Ratio
120.9
Revenue / Employee
14.08K
Employees
200
Market Cap
104.7M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.82M | -86.62% |
| Dec 31, 2023 | 21.05M | +55.52% |
| Dec 31, 2022 | 13.54M | +33.47% |
| Dec 31, 2021 | 10.14M | +834.65% |
| Dec 31, 2020 | 1.08M | +Infinity% |
| Dec 31, 2019 | 0 | n/a |